Symbols / ELAB $3.84 -32.87% PMGC Holdings Inc.

Healthcare • Biotechnology • United States • NCM
ELAB Chart
About

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 4.45M
Enterprise Value 3.30M Income -7.78M Sales 590.08K
Book/sh 97.11 Cash/sh 5.15 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E — PEG —
P/S 7.54 P/B 0.04 P/C —
EV/EBITDA -0.47 EV/Sales 5.59 Quick Ratio 1.60
Current Ratio 1.74 Debt/Eq 33.75 LT Debt/Eq —
EPS (ttm) -382.61 EPS next Y — EPS Growth —
Revenue Growth — Earnings — ROA -40.73%
ROE -107.34% ROIC — Gross Margin -90.21%
Oper. Margin -9.45% Profit Margin 0.00% Shs Outstand 1.16M
Shs Float 1.15M Short Float 6.11% Short Ratio 0.21
Short Interest — 52W High 467.37 52W Low 1.62
Beta — Avg Volume 5.11M Volume 8.11M
Target Price — Recom None Prev Close $5.72
Price $3.84 Change -32.87%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$3.84
Latest analyst target
3. DCF / Fair value
$-53.12
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.84
Low
—
High
—
Mean
—
News
RSS: Latest ELAB news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.59
0.00
0.00
-100.00%
0.77
Operating Revenue
0.59
0.00
0.00
-100.00%
0.77
Cost Of Revenue
0.40
0.00
-100.00%
0.58
+81.21%
0.32
Reconciled Cost Of Revenue
0.40
0.00
-100.00%
0.58
+81.63%
0.32
Gross Profit
0.19
0.00
-100.00%
1.13
+153.65%
0.45
Operating Expense
7.01
+91.56%
3.66
+222.31%
1.13
-49.24%
2.24
Research And Development
0.15
+40.47%
0.10
+1312.33%
0.01
-96.76%
0.23
Selling General And Administration
5.63
+69.87%
3.32
+226.19%
1.02
-41.22%
1.73
Selling And Marketing Expense
0.20
-31.31%
0.29
+14.07%
0.26
+32.97%
0.19
General And Administrative Expense
5.43
+79.66%
3.02
+297.76%
0.76
-50.54%
1.54
Salaries And Wages
0.17
+0.95%
0.17
-91.14%
1.86
+138.17%
0.78
Other Gand A
5.26
+84.20%
2.86
+276.05%
0.76
+11.63%
0.68
Other Operating Expenses
1.13
+377.56%
0.24
+114.60%
0.11
-59.48%
0.27
Total Expenses
7.41
+102.62%
3.66
+222.31%
1.13
-55.58%
2.55
Operating Income
-6.82
-86.49%
-3.66
-222.31%
-1.13
+36.54%
-1.79
EBITDA
-7.40
-126.26%
-3.27
-98.69%
-1.65
+8.15%
-1.79
Normalized EBITDA
-6.86
-88.97%
-3.63
-224.97%
-1.12
+37.00%
-1.77
Reconciled Depreciation
0.10
+646.43%
0.01
+11.17%
0.01
+78.89%
0.01
EBIT
-7.49
-128.31%
-3.28
-98.07%
-1.66
+7.84%
-1.80
Total Unusual Items
-0.53
-246.55%
0.36
+168.88%
-0.53
-2993.88%
-0.02
Total Unusual Items Excluding Goodwill
-0.53
-246.55%
0.36
+168.88%
-0.53
-2993.88%
-0.02
Special Income Charges
-0.43
0.00
+100.00%
-0.45
-29012.48%
-0.00
Other Special Charges
-0.03
—
0.45
—
Write Off
0.56
0.00
—
—
Net Income
-7.75
-24.05%
-6.25
-45.20%
-4.30
-138.94%
-1.80
Pretax Income
-7.75
-92.94%
-4.02
-142.45%
-1.66
+7.97%
-1.80
Net Non Operating Interest Income Expense
-0.43
+40.59%
-0.72
-13081.78%
0.01
+9.68%
0.01
Interest Expense Non Operating
0.26
-64.96%
0.74
0.00
-100.00%
0.00
Net Interest Income
-0.43
+40.59%
-0.72
-13081.78%
0.01
+9.68%
0.01
Interest Expense
0.26
-64.96%
0.74
0.00
-100.00%
0.00
Interest Income Non Operating
0.12
+815.60%
0.01
+131.69%
0.01
-27.76%
0.01
Interest Income
0.12
+815.60%
0.01
+131.69%
0.01
-27.76%
0.01
Other Income Expense
-0.50
-237.44%
0.36
+168.88%
-0.53
-2993.88%
-0.02
Other Non Operating Income Expenses
0.03
—
—
—
Gain On Sale Of Security
-0.11
-129.03%
0.36
+569.42%
-0.08
-399.23%
-0.02
Tax Provision
0.03
0.00
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
-0.11
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-7.75
-24.05%
-6.25
-45.20%
-4.30
-138.94%
-1.80
Net Income From Continuing Operation Net Minority Interest
-7.78
-93.71%
-4.02
-142.45%
-1.66
+7.97%
-1.80
Net Income From Continuing And Discontinued Operation
-7.75
-24.05%
-6.25
-45.20%
-4.30
-138.94%
-1.80
Net Income Continuous Operations
-7.78
-93.71%
-4.02
-142.45%
-1.66
+7.97%
-1.80
Net Income Discontinuous Operations
0.03
+101.48%
-2.23
+15.72%
-2.64
—
Normalized Income
-7.36
-68.04%
-4.38
-287.87%
-1.13
+36.67%
-1.78
Net Income Common Stockholders
-7.75
-24.05%
-6.25
-45.20%
-4.30
-138.94%
-1.80
Diluted EPS
-380.99
+68.12%
-1,195.13
+95.92%
-29,262.02
-138.94%
-12,246.72
Basic EPS
-380.99
+68.12%
-1,195.13
+95.92%
-29,262.02
-138.94%
-12,246.72
Basic Average Shares
0.02
+289.11%
0.01
+3455.10%
0.00
+0.00%
0.00
Diluted Average Shares
0.02
+289.11%
0.01
+3455.10%
0.00
+0.00%
0.00
Diluted NI Availto Com Stockholders
-7.75
-24.05%
-6.25
-45.20%
-4.30
-138.94%
-1.80
Depreciation Amortization Depletion Income Statement
0.10
+17508.97%
0.00
-1.44%
0.00
-88.99%
0.01
Depreciation And Amortization In Income Statement
0.10
+17508.97%
0.00
-1.44%
0.00
-88.99%
0.01
Depreciation Income Statement
—
0.00
-1.44%
0.00
-88.99%
0.01
Gain On Sale Of PPE
0.10
0.00
0.00
+100.00%
-0.00
Rent And Landing Fees
—
—
0.13
+71.88%
0.07
Rent Expense Supplemental
—
—
0.13
+71.88%
0.07
Total Other Finance Cost
0.29
—
—
—
Line Item Trend 2025-12-31
Total Assets
12.87
Current Assets
6.87
Cash Cash Equivalents And Short Term Investments
5.97
Cash And Cash Equivalents
5.40
Cash Financial
5.40
Other Short Term Investments
0.57
Receivables
0.34
Accounts Receivable
0.25
Other Receivables
0.10
Taxes Receivable
—
Inventory
0.10
Raw Materials
0.01
Work In Process
—
Finished Goods
0.09
Prepaid Assets
0.46
Assets Held For Sale Current
0.00
Total Non Current Assets
6.00
Net PPE
2.13
Gross PPE
2.18
Accumulated Depreciation
-0.05
Properties
0.00
Machinery Furniture Equipment
0.89
Other Properties
1.24
Leases
0.05
Goodwill And Other Intangible Assets
3.87
Goodwill
0.98
Other Intangible Assets
2.89
Investments And Advances
0.00
Non Current Prepaid Assets
—
Other Non Current Assets
—
Total Liabilities Net Minority Interest
5.03
Current Liabilities
3.94
Payables And Accrued Expenses
1.94
Payables
1.94
Accounts Payable
0.70
Other Payable
0.21
Current Accrued Expenses
—
Current Debt And Capital Lease Obligation
1.59
Current Debt
1.34
Other Current Borrowings
1.34
Current Capital Lease Obligation
0.25
Current Deferred Liabilities
—
Current Deferred Revenue
—
Other Current Liabilities
0.42
Total Non Current Liabilities Net Minority Interest
1.09
Liabilities Heldfor Sale Non Current
—
Long Term Debt And Capital Lease Obligation
1.06
Long Term Debt
0.09
Long Term Capital Lease Obligation
0.97
Tradeand Other Payables Non Current
0.00
Non Current Deferred Liabilities
0.03
Non Current Deferred Taxes Liabilities
0.03
Stockholders Equity
7.84
Common Stock Equity
7.84
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
0.08
Ordinary Shares Number
0.08
Treasury Shares Number
0.00
Additional Paid In Capital
28.86
Retained Earnings
-21.02
Gains Losses Not Affecting Retained Earnings
-0.00
Other Equity Adjustments
-0.00
Total Equity Gross Minority Interest
7.84
Total Capitalization
7.92
Working Capital
2.93
Invested Capital
9.26
Total Debt
2.64
Capital Lease Obligations
1.22
Net Tangible Assets
3.97
Tangible Book Value
3.97
Available For Sale Securities
—
Dueto Related Parties Current
1.03
Investmentin Financial Assets
0.00
Preferred Stock Equity
0.00
Trading Securities
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-5.93
-8.14%
-5.49
-20.41%
-4.56
-187.34%
-1.59
Cash Flow From Continuing Operating Activities
-5.93
-8.14%
-5.49
-20.41%
-4.56
-187.34%
-1.59
Net Income From Continuing Operations
-7.75
-24.05%
-6.25
-45.20%
-4.30
-138.94%
-1.80
Depreciation Amortization Depletion
0.10
+646.43%
0.01
+11.17%
0.01
+78.89%
0.01
Depreciation
0.10
+646.43%
0.01
+11.17%
0.01
+78.89%
0.01
Depreciation And Amortization
0.10
+646.43%
0.01
+11.17%
0.01
+78.89%
0.01
Other Non Cash Items
0.53
-30.18%
0.77
+27888.61%
-0.00
-129.72%
0.01
Stock Based Compensation
-0.02
-119.72%
0.10
-80.08%
0.49
+183.78%
0.17
Provisionand Write Offof Assets
0.06
0.00
—
—
Asset Impairment Charge
0.50
0.00
—
—
Deferred Tax
0.03
0.00
—
—
Deferred Income Tax
0.03
0.00
—
—
Operating Gains Losses
-0.19
+48.80%
-0.37
-618.00%
0.07
+398.36%
0.01
Gain Loss On Investment Securities
-0.10
+72.84%
-0.37
-618.00%
0.07
+458.77%
0.01
Unrealized Gain Loss On Investment Securities
0.22
0.00
—
—
Gain Loss On Sale Of PPE
-0.10
0.00
0.00
-100.00%
0.00
Change In Working Capital
0.59
+133.69%
0.25
+130.57%
-0.82
-6721.01%
0.01
Change In Receivables
-0.10
-675.65%
-0.01
+44.14%
-0.02
-101.07%
-0.01
Change In Inventory
0.15
+136.66%
-0.40
-51.89%
-0.27
-282.99%
-0.07
Change In Prepaid Assets
0.00
-97.99%
0.07
+107.17%
-0.91
-789.07%
-0.10
Change In Payables And Accrued Expense
0.56
-7.47%
0.61
+74.73%
0.35
+87.04%
0.19
Change In Payable
0.56
-7.47%
0.61
+74.73%
0.35
+87.04%
0.19
Change In Account Payable
0.96
+361.58%
0.21
-55.56%
0.47
+616.19%
0.07
Change In Other Working Capital
-0.02
-757.21%
-0.00
-109.02%
0.03
+160.73%
0.01
Investing Cash Flow
-2.77
-352.89%
-0.61
-5355.85%
-0.01
+65.06%
-0.03
Cash Flow From Continuing Investing Activities
-2.77
-352.89%
-0.61
-5355.85%
-0.01
+65.06%
-0.03
Net PPE Purchase And Sale
-0.44
-4728.11%
-0.01
+18.15%
-0.01
+65.06%
-0.03
Purchase Of PPE
-0.44
-4728.11%
-0.01
+18.15%
-0.01
+68.50%
-0.04
Sale Of PPE
—
—
0.00
-100.00%
0.00
Capital Expenditure
-0.45
+4.93%
-0.47
-4113.03%
-0.01
+68.50%
-0.04
Net Investment Purchase And Sale
-0.03
+80.70%
-0.14
0.00
—
Purchase Of Investment
-1.79
-1186.30%
-0.14
0.00
—
Sale Of Investment
1.76
0.00
—
—
Net Business Purchase And Sale
-2.16
0.00
—
—
Purchase Of Business
-2.16
0.00
—
—
Gain Loss On Sale Of Business
0.04
0.00
—
—
Net Intangibles Purchase And Sale
-0.01
+98.70%
-0.46
0.00
—
Purchase Of Intangibles
-0.01
+98.70%
-0.46
0.00
—
Net Other Investing Changes
-0.13
—
—
—
Financing Cash Flow
10.12
+49.71%
6.76
+0.28%
6.74
+185.27%
2.36
Cash Flow From Continuing Financing Activities
10.12
+49.71%
6.76
+0.28%
6.74
+185.27%
2.36
Net Issuance Payments Of Debt
0.00
+100.00%
-0.24
0.00
-100.00%
0.18
Issuance Of Debt
0.00
-100.00%
0.91
0.00
-100.00%
0.18
Repayment Of Debt
0.00
+100.00%
-1.15
0.00
—
Long Term Debt Issuance
0.00
-100.00%
0.91
0.00
—
Long Term Debt Payments
0.00
+100.00%
-1.15
0.00
—
Net Long Term Debt Issuance
0.00
+100.00%
-0.24
0.00
—
Short Term Debt Issuance
—
—
0.00
-100.00%
0.18
Net Short Term Debt Issuance
—
—
0.00
-100.00%
0.18
Net Common Stock Issuance
2.92
-58.28%
6.99
+4.35%
6.70
0.00
Common Stock Payments
-0.00
0.00
—
—
Repurchase Of Capital Stock
-0.00
0.00
—
—
Proceeds From Stock Option Exercised
3.21
0.00
-100.00%
0.04
+50.00%
0.03
Net Other Financing Charges
3.99
—
-0.76
—
Changes In Cash
1.42
+114.82%
0.66
-69.60%
2.17
+191.65%
0.74
Effect Of Exchange Rate Changes
0.00
+107.52%
-0.00
-321.66%
0.00
+180.88%
-0.00
Beginning Cash Position
3.98
+19.77%
3.33
+188.06%
1.15
+180.41%
0.41
End Cash Position
5.40
+35.59%
3.98
+19.77%
3.33
+188.06%
1.15
Free Cash Flow
-6.38
-7.11%
-5.96
-30.44%
-4.57
-181.73%
-1.62
Interest Paid Supplemental Data
0.04
-45.28%
0.07
+379.45%
0.01
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
2.92
-58.28%
6.99
+4.35%
6.70
0.00
Issuance Of Capital Stock
2.92
-58.28%
6.99
+4.35%
6.70
+211.22%
2.15
Net Preferred Stock Issuance
—
—
0.00
-100.00%
2.15
Preferred Stock Issuance
—
—
0.00
-100.00%
2.15
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category